Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Alliance for Microbicide Development (AMD) was a prominent non-profit organization that operated from 1998 to 2010, focusing on the advancement of microbicides for HIV prevention. As a multisectoral coalition, it brought together researchers, policymakers, and advocacy groups to streamline the development and regulatory pathways for topical prevention technologies. The Alliance was instrumental in tracking the global microbicide pipeline and advocating for increased public and private investment in women-controlled HIV prevention methods. Headquartered in Silver Spring, Maryland, the organization played a pivotal role in the early coordination of the microbicide field before dissolving as the landscape shifted toward integrated biomedical prevention strategies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alliance for Microbicide Development.